Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AVGO NASDAQ:MKTX NASDAQ:NFLX NASDAQ:REGN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGOBroadcom$439.79+5.5%$363.46$221.60▼$442.36$1.97T1.4319.31 million shs19.66 million shsMKTXMarketAxess$140.51+0.9%$167.54$137.27▼$228.16$4.95B0.92529,313 shs420,828 shsNFLXNetflix$86.94-0.7%$94.98$75.01▼$134.12$368.70B1.5544.07 million shs29.35 million shsREGNRegeneron Pharmaceuticals$712.87-1.0%$746.47$476.49▼$821.11$76.11B0.3796,250 shs767,153 shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGOBroadcom+5.52%+6.60%+15.58%+35.25%+89.47%MKTXMarketAxess+0.88%-7.96%-17.84%-21.66%-33.35%NFLXNetflix-0.71%-1.51%-18.11%+13.10%-24.47%REGNRegeneron Pharmaceuticals-0.97%+0.53%-5.64%-11.24%+24.77%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVGOBroadcom$439.79+5.5%$363.46$221.60▼$442.36$1.97T1.4319.31 million shs19.66 million shsMKTXMarketAxess$140.51+0.9%$167.54$137.27▼$228.16$4.95B0.92529,313 shs420,828 shsNFLXNetflix$86.94-0.7%$94.98$75.01▼$134.12$368.70B1.5544.07 million shs29.35 million shsREGNRegeneron Pharmaceuticals$712.87-1.0%$746.47$476.49▼$821.11$76.11B0.3796,250 shs767,153 shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVGOBroadcom+5.52%+6.60%+15.58%+35.25%+89.47%MKTXMarketAxess+0.88%-7.96%-17.84%-21.66%-33.35%NFLXNetflix-0.71%-1.51%-18.11%+13.10%-24.47%REGNRegeneron Pharmaceuticals-0.97%+0.53%-5.64%-11.24%+24.77%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVGOBroadcom 2.94Moderate Buy$439.970.04% UpsideMKTXMarketAxess 2.11Hold$190.8835.84% UpsideNFLXNetflix 2.73Moderate Buy$114.8232.07% UpsideREGNRegeneron Pharmaceuticals 2.77Moderate Buy$826.5915.95% UpsideCurrent Analyst Ratings BreakdownLatest NFLX, MKTX, AVGO, and REGN Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2026NFLXNetflix TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/14/2026NFLXNetflix Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingMarket Perform5/14/2026AVGOBroadcom Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$430.00 ➝ $545.005/14/2026NFLXNetflix Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/12/2026AVGOBroadcom CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$475.00 ➝ $500.005/11/2026MKTXMarketAxess UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$225.00 ➝ $215.005/11/2026MKTXMarketAxess BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$189.00 ➝ $170.005/6/2026MKTXMarketAxess Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold (C-) ➝ Sell (D+)5/4/2026NFLXNetflix Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C) ➝ Hold (C+)5/1/2026REGNRegeneron Pharmaceuticals GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$975.00 ➝ $995.004/30/2026REGNRegeneron Pharmaceuticals Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$779.00 ➝ $762.00(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVGOBroadcom$63.89B32.59$8.13 per share54.10$17.15 per share25.64MKTXMarketAxess$846.27M5.90$9.73 per share14.44$33.49 per share4.20NFLXNetflix$45.18B8.10$6.52 per share13.33$7.39 per share11.76REGNRegeneron Pharmaceuticals$14.34B5.25$41.57 per share17.15$297.23 per share2.40Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVGOBroadcom$23.13B$5.1285.9026.930.8636.57%38.61%17.49%6/3/2026 (Estimated)MKTXMarketAxess$246.63M$8.4616.6115.892.6735.53%22.28%13.82%N/ANFLXNetflix$10.98B$3.1028.0822.581.1128.52%40.92%19.79%7/16/2026 (Estimated)REGNRegeneron Pharmaceuticals$4.50B$41.0417.3717.171.6029.65%13.16%10.17%7/30/2026 (Estimated)Latest NFLX, MKTX, AVGO, and REGN EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/3/2026Q2 2026AVGOBroadcom$2.40N/AN/AN/A$22.03 billionN/A5/7/2026Q1 2026MKTXMarketAxess$2.15$2.25+$0.10$2.20$231.91 million$233.38 million4/29/2026Q1 2026REGNRegeneron Pharmaceuticals$8.91$9.47+$0.56$6.75$3.48 billion$3.61 billion4/16/2026Q1 2026NFLXNetflix$0.7590$1.23+$0.4710$1.23$12.17 billion$12.25 billion3/4/2026Q1 2026AVGOBroadcom$2.03$2.05+$0.02$1.50$19.10 billion$19.31 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAVGOBroadcom$2.600.59%+12.67%50.78%15 YearsMKTXMarketAxess$3.122.22%+4.84%36.88%2 YearsNFLXNetflixN/AN/AN/AN/AN/AREGNRegeneron Pharmaceuticals$3.760.53%N/A9.16%N/ALatest NFLX, MKTX, AVGO, and REGN DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/29/2026REGNRegeneron Pharmaceuticalsquarterly$0.940.55%5/20/20265/20/20266/4/20264/15/2026MKTXMarketAxessquarterly$0.782.04%5/20/20265/20/20266/3/20263/3/2026AVGOBroadcomQuarterly$0.650.81%3/23/20263/23/20263/31/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVGOBroadcom0.801.901.73MKTXMarketAxess0.192.172.17NFLXNetflix0.431.411.41REGNRegeneron Pharmaceuticals0.063.572.96Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVGOBroadcom76.43%MKTXMarketAxess99.01%NFLXNetflix80.93%REGNRegeneron Pharmaceuticals83.31%Insider OwnershipCompanyInsider OwnershipAVGOBroadcom1.90%MKTXMarketAxess0.72%NFLXNetflix1.37%REGNRegeneron Pharmaceuticals6.97%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVGOBroadcom33,0004.73 billion4.64 billionOptionableMKTXMarketAxess74035.54 million35.28 millionOptionableNFLXNetflix16,0004.21 billion4.15 billionOptionableREGNRegeneron Pharmaceuticals15,410105.72 million98.35 millionOptionableNFLX, MKTX, AVGO, and REGN HeadlinesRecent News About These CompaniesSimmons Bank Purchases New Shares in Regeneron Pharmaceuticals, Inc. $REGN2 hours ago | marketbeat.comBank Julius Baer & Co. Ltd Zurich Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN4 hours ago | marketbeat.comFreemont Management S.A. Takes $5.09 Million Position in Regeneron Pharmaceuticals, Inc. $REGNMay 14 at 4:13 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. $REGN Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET AlMay 13 at 7:43 AM | marketbeat.comSwiss Life Asset Management Ltd Has $8.31 Million Stake in Regeneron Pharmaceuticals, Inc. $REGNMay 13 at 5:42 AM | marketbeat.comRegeneron Pharmaceuticals, Inc. (REGN) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12 at 4:11 PM | seekingalpha.comNTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in FocusMay 12 at 1:28 PM | finance.yahoo.comRegeneron Pharmaceuticals, Inc. $REGN Shares Sold by Securian Asset Management Inc.May 12 at 5:58 AM | marketbeat.comIs Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?May 11, 2026 | finance.yahoo.comIs Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?May 11, 2026 | insidermonkey.comPeak Wealth Management LLC Invests $4.02 Million in Regeneron Pharmaceuticals, Inc. $REGNMay 11, 2026 | marketbeat.comOsprey Private Wealth LLC Grows Position in Regeneron Pharmaceuticals, Inc. $REGNMay 10, 2026 | marketbeat.comRegeneron’s Otarmeni Win Links Gene Therapy Ambition With ESG CommitmentsMay 9, 2026 | finance.yahoo.comGenerali Asset Management SPA SGR Reduces Position in Regeneron Pharmaceuticals, Inc. $REGNMay 9, 2026 | marketbeat.comF m Investments LLC Has $17.61 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGNMay 9, 2026 | marketbeat.comRegeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive YearsMay 8, 2026 | finance.yahoo.comRegeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive YearsMay 8, 2026 | globenewswire.comIs This Biotech Stock a Buy After a Groundbreaking Approval?May 8, 2026 | fool.comLilly and Regeneron Advance Obesity Combo Bet as Key Tirzepatide Trial Reaches CompletionMay 7, 2026 | tipranks.comTrump’s Affordability Push Stalls Ahead of Midterm ElectionsMay 7, 2026 | finance.yahoo.comLmcg Investments LLC Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGNMay 7, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesWhy Netflix Tanked Despite Big EPS Beat, Outlook AheadBy Leo Miller | April 17, 2026Big-Tech Earnings: Google and Meta's Results Support Broadcom's OutlookBy Leo Miller | May 4, 2026Netflix's Pivot to Profit: The New Discretionary Blue ChipBy Jeffrey Neal Johnson | April 25, 2026Netflix, Pulte, and Mobileye Are Buying Their Own Dips—Should You?By Leo Miller | May 4, 2026Broadcom Hits $2 Trillion Market Cap as Google Reveals New AI ChipsBy Leo Miller | April 28, 2026NFLX, MKTX, AVGO, and REGN Company DescriptionsBroadcom NASDAQ:AVGO$439.79 +23.00 (+5.52%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$428.90 -10.89 (-2.48%) As of 08:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Broadcom Inc. designs, develops, and supplies various semiconductor devices with a focus on complex digital and mixed signal complementary metal oxide semiconductor based devices and analog III-V based products worldwide. The company operates in two segments, Semiconductor Solutions and Infrastructure Software. It provides set-top box system-on-chips (SoCs); cable, digital subscriber line, and passive optical networking central office/consumer premise equipment SoCs; wireless local area network access point SoCs; Ethernet switching and routing custom silicon solutions; serializer/deserializer application specific integrated circuits; optical and copper, and physical layer devices; and fiber optic components and RF semiconductor devices. The company also offers RF front end modules and filter; Wi-Fi, Bluetooth, and global positioning system/global navigation satellite system SoCs; custom touch controllers; inductive charging; attached small computer system interface, and redundant array of independent disks controllers and adapters; peripheral component interconnect express; fiber channel host bus adapters; read channel based SoCs; custom flash controllers; preamplifiers; optocouplers, industrial fiber optics, and motion control encoders and subsystems; light emitting diode, ethernet PHYs, switch ICs, and camera microcontrollers. Its products are used in various applications, including enterprise and data center networking, home connectivity, set-top boxes, broadband access, telecommunication equipment, smartphones and base stations, data center servers and storage systems, factory automation, power generation and alternative energy systems, and electronic displays. Broadcom Inc. was founded in 1961 and is headquartered in Palo Alto, California.MarketAxess NASDAQ:MKTX$140.51 +1.23 (+0.88%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$140.55 +0.04 (+0.03%) As of 06:54 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.MarketAxess Holdings Inc., together with its subsidiaries, operates an electronic trading platform for institutional investor and broker-dealer companies worldwide. The company offers trading technology that provides liquidity access in U.S. high-grade bonds, U.S. high-yield bonds, emerging market debt, eurobonds, municipal bonds, U.S. government bonds, and other fixed-income securities; and executes bond trades between and among institutional investor and broker-dealer clients in an all-to-all anonymous trading environment for corporate bonds through its Open Trading protocols. It also provides trading-related products and services, including composite+ pricing and other market data products to assist clients with trading decisions; auto-execution and other execution services for clients requiring specialized workflow solutions; connectivity solutions that facilitate straight-through processing; and technology services to optimize trading environments. In addition, the company offers various pre-and post-trade services, such as trade matching, trade publication, regulatory transaction reporting, and market and reference data across a range of fixed-income and other products. MarketAxess Holdings Inc. was incorporated in 2000 and is headquartered in New York, New York.Netflix NASDAQ:NFLX$86.94 -0.62 (-0.71%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$87.07 +0.13 (+0.15%) As of 08:12 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Netflix, Inc. provides entertainment services. It offers TV series, documentaries, feature films, and games across various genres and languages. The company also provides members the ability to receive streaming content through a host of internet-connected devices, including TVs, digital video players, TV set-top boxes, and mobile devices. It has operations in approximately 190 countries. The company was incorporated in 1997 and is headquartered in Los Gatos, California.Regeneron Pharmaceuticals NASDAQ:REGN$712.87 -7.01 (-0.97%) Closing price 05/14/2026 04:00 PM EasternExtended Trading$716.45 +3.58 (+0.50%) As of 08:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; and retinopathy of prematurity. It also provides Dupixent injection to treat atopic dermatitis and asthma in adults and pediatrics; Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; REGEN-COV for covid-19; and Kevzara solution for treating rheumatoid arthritis in adults. In addition, the company offers Inmazeb injection for infection caused by Zaire ebolavirus; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer; and develops product candidates for treating patients with eye, allergic and inflammatory, cardiovascular and metabolic, infectious, and rare diseases; and cancer, pain, and hematologic conditions. It has collaboration with Mammoth Biosciences, Inc. to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and cell types. The company was incorporated in 1988 and is headquartered in Tarrytown, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas YETI Rallies After Earnings Beat and Raised Outlook Cisco’s Vertical Rally May Still Be in the Early Innings Be Ready: 3 Upcoming Catalysts Could Drive Oracle to Record Highs Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies 2 Ways to Play the Big Pharma Patent Cliff Oklo Stock Could Be Ready for Another Massive Run Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
